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Background: Histone deacetylases (HDACs) play important roles in glial cell development and in disease states
within multiple regions of the central nervous system. However, little is known about HDAC expression or function
within the optic nerve. As a first step in understanding the role of HDACs in optic nerve, this study examines the
spatio-temporal expression patterns of methylated histone 3 (K9), acetylated histone 3 (K18), and HDACs 1–6 and
8–11 in the developing murine optic nerve head.
Results: Using RT-qPCR, western blot and immunofluorescence, three stages were analyzed: embryonic day 16
(E16), when astrocyte precursors are found in the optic stalk, postnatal day 5 (P5), when immature astrocytes and
oligodendrocytes are found throughout the optic nerve, and P30, when optic nerve astrocytes and oligodendrocytes
are mature. Acetylated and methylated histone H3 immunoreactivity was co-localized in the nuclei of most SOX2
positive glia within the optic nerve head and adjacent optic nerve at all developmental stages. HDACs 1–11 were
expressed in the optic nerve glial cells at all three stages of optic nerve development in the mouse, but showed
temporal differences in overall levels and subcellular localization. HDACs 1 and 2 were predominantly nuclear throughout
optic nerve development and glial cell maturation. HDACs 3, 5, 6, 8, and 11 were predominantly cytoplasmic, but
showed nuclear localization in at least one stage of optic nerve development. HDACs 4, 9 and10 were predominantly
cytoplasmic, with little to no nuclear expression at any time during the developmental stages examined.
Conclusions: Our results showing that HDACs 1, 2, 3, 5, 6, 8, and 11 were each localized to the nuclei of SOX2 positive
glia at some stages of optic nerve development and maturation and extend previous reports of HDAC expression in the
aging optic nerve. These HDACs are candidates for further research to understand how chromatin remodeling through
acetylation, deacetylation and methylation contributes to glial development as well as their injury response.
Keywords: Histone deacetylases, HDACs, Mouse, Murine, Development, Optic nerve, Optic stalk, Astrocytes, Astrocyte
precursors, Glial laminaBackground
Astrocytes, once thought to be relatively inert cells, have
been shown to play a multitude of roles in the develop-
ing, mature, and injured or diseased central nervous
system [1,2]. For instance, astrocytes play key roles in
synaptogenesis, maintenance of ion and transmitter
levels, metabolic homeostasis, and support of neurons
following injury [3]. Despite their importance, there still* Correspondence: tbadams@iupui.edu
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for the differentiation of these cells.
Within the mature optic nerve, there are 3 macroglial
cell types: type I and type II astrocytes and oligodendro-
cytes [4]. Type I astrocytes arise from the PAX2-
expressing neuroepithelial cells of embryonic optic stalk
and a subpopulation of these cells migrate from the
optic stalk onto the retinal surface where they associate
with the surface vasculature to form the blood/retinal
barrier [5-7]. Additional type I astrocytes from this
lineage remain in the optic nerve adjacent to the globe
within the glial lamina, a network of collagenous beams
invested with astrocytes that is analogous to the lamina
cribrosa in humans [8]. Oligodendrocytes, the myelin-
forming cells of the CNS, arise from oligodendrocytetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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alon into the optic nerve via the optic chiasm. Oligo-
dendrocyte precursor cells also give rise to type II
astrocytes, at least in vitro, but there are conflicting re-
ports in the literature as to whether this also occurs
in vivo [4,9]. There is increasing understanding of the se-
creted external and internal signals necessary for glial
cells to develop, including leukemia inhibitory factor
(LIF), bone morphogenetic proteins (BMPs), sonic hedge-
hog (SHH) and their intracellular signaling pathways
[7,10-12]. There is also evidence that epigenetic factors
cooperate with signaling in these three pathways [13,14].
However, little is known about the role that specific epi-
genetic factors play in the development of optic nerve
glia.
Epigenetics is the study of factors that change tran-
scriptional activity without changing the sequence of the
DNA itself. These factors include DNA methylation and
histone modifications [15]. Histones can be modified
through post-translational modifications such as acetyl-
ation, phosphorylation, methylation, ubiquitination, and
sumoylation [16]. Acetylation of histone tails is regulated
by two large families of enzymes: histone acetyl transfer-
ases (HATs) and histone deacetylases (HDACs). Addition
of acetyl groups to the histones offsets the positive charge
on histone tails, resulting in relaxation of the chromatin
structure, which, in turn, leads to greater accessibility of
general and cell-type specific transcription factors to bind-
ing elements within the DNA [17]. HDACs are typically
associated with transcriptional repression, although there
are also reports that associate HDAC activity with tran-
scriptional activation [18,19]. Further, both HATs and
HDACs can respectively acetylate and deacetylate non-
histone proteins in the cytoplasm, thereby affecting pro-
tein expression or function [20-25].
Whereas HDACs are known to play important roles in
glial cell development and in disease states within other
regions of the central nervous system, there is no infor-
mation about HDAC expression patterns in developing
optic nerve. Here, the spatio-temporal expression pat-
terns of methylated histone 3 (K9), acetylated histone 3
(K18), and the HDACs 1–6 and 8–11 in the developing
murine optic nerve have been determined, focusing on
the peripapillary and glial laminar regions. Using RT-
qPCR and western blot analysis, we established that
HDACs 1–11 are expressed in optic nerve. Double-label
immunohistochemistry indicated three patterns among
optic nerve glia: 1) primarily nuclear localization (HDACs
1 and 2), 2) cytoplasmic and nuclear at one or more stages
of development (HDACs 3, 5, 6, 8 and 11) and 3) cytoplas-
mic at all stages analyzed (HDACs 4, 9, 10). This study is
a critical first step in identifying HDACs that may be in-
volved in chromatin conformation during optic nerve
astrocyte differentiation and will also establish a baselinefor normal expression patterns of HDACs to enable com-
parison with disease states in the optic nerve.
Results
Acetylation and methylation in the murine optic nerve
The presence of acetylated (K18) and methylated (K9)
histone 3, representing active and repressed chromatin
within the genome respectively, was determined using
triple-label immunofluorescence on sections through de-
veloping mouse optic nerve. Three different stages of de-
velopment were chosen for these studies; embryonic day
16 (E16), which is a period when astrocyte precursors
are found in the nascent optic nerve, postnatal day 5
(P5) when immature astrocytes are found throughout
the optic nerve, including the optic nerve head and
developing lamina and P30 when the glia within the
lamina, as well as the optic nerve astrocytes and oligo-
dendrocytes are mature [26-28].
Sections through the optic nerve head and adjacent
optic nerve were triple-labeled with antibodies against
SOX2, which labels glia in the peripapillary, laminar and
optic nerve regions, and antibodies against methylated his-
tone H3 (MeH3K9) and acetylated histone H3 (AcH3K18)
as markers of closed and open chromatin structure re-
spectively. Within the optic nerve in the low magnifica-
tion image of a triple-stained P30 section (Figure 1B),
SOX2-immuno positive (SOX2+) glial cells located with-
in 100 microns of the optic globe showed the character-
istic elongation across the optic nerve that typifies the
laminar region; glial nuclei located beyond the lamina
were typically rounded or elongated in parallel to the
optic nerve [29].
Within the optic nerve, the majority of SOX2+ nuclei
were immunopositive for both MeH3K9 and AcH3K18.
Along the external surface of the optic nerve, the major-
ity of cells were SOX2 (−) and MeH3K9 (+). Within the
population of extraocular SOX2 (−) cells, AcH3K18 stain-
ing was co-localized with MeH3K9 in a subset of cells. The
SOX2(−), MeH3K9+ cells located furthest from the optic
nerve head were most likely non-glial cells associated with
the outer surface of the optic nerve that were revealed by
the oblique angle of the section through the optic nerve.
At higher magnification, the majority of SOX2+ nuclei
within the developing optic nerve at E16 (Figure 1D-G)
and within the laminar area at P5 (Figure 1H-K) and
P30 (Figure 1L-O) were co-labeled by antibodies for
AcH3K18 and MeH3K9. The nuclei of many of the im-
mature astrocytes at E16 were elongated in parallel to
the optic nerve, consistent with the migration of astro-
cyte precursors towards the optic nerve head and retinal
nerve fiber layer where they will differentiate into retinal
astrocytes (Figure 1G). As development proceeded,
nuclei of SOX2+ glial cells located in the optic nerve im-
mediately posterior to the globe manifested the cross-
Figure 1 Acetylated H3K18 and methylated H3K9 localization in the developing murine optic nerve. (A) Drawing showing the plane of
sectioning used throughout the study. (B) Low magnification view of the postnatal day 30 (P30) optic nerve (ON) optic nerve head and retina (R)
stained with antibodies against SOX2 (green), MeH3K9 (blue) and acH3K18 (red). (C) Drawing showing the orientation of the optic nerve and
retina in photomicrographs; the boxed area indicates the regions shown at higher magnification in panels D-O. Higher magnification of murine
optic nerve is shown at E16 (D-G), P5 (H-K) and P30 (L-O). Arrows in D-F, H-J and L-N indicate triple labeled cells. Arrowheads indicate SOX2
positive cells co-labeled with MeH3K9 but negative for AcH3K18 (G, K, L, M and N). Composite images in G, K and O show z stacks of optic
nerve at high magnification; horizontal yellow lines correspond the x axis plane and vertical yellow lines corresponds to the y axis. The x, z axis is
shown at the bottom of each panel, while the y,z axis is shown to the right of the panel. Abbreviations: R; retina, ON; optic nerve. Scale bars = 50 μm;
Scale bar in D applies to D-F, H-J, and I-N, bar in G applies to G, K and O.
Tiwari et al. BMC Developmental Biology 2014, 14:30 Page 3 of 18
http://www.biomedcentral.com/1471-213X/14/30wise elongation characteristic of the developing glial
lamina (Figure 1K, O).
mRNA expression levels in the murine optic nerve glia
The presence of acetylated and methylated histones in
optic nerve nuclei, coupled with published reports that
glial cell fate decisions require deacetylation, led us to
ask which HDACs might be involved in this process
[30,31]. To determine which members of the large family
of Hdacs were expressed in the optic nerve, reverse
transcription quantitative polymerase chain reaction
(RT-qPCR) was performed on murine optic nerve RNA.
RT-qPCR clearly indicated that mRNAs encoding Hdacs1–11 were present at E16, P5, and P30 in the murine
optic nerve (Figure 2). Each of the Hdac expression
levels from E16, P5 and P30 were normalized to the geo-
metric mean of β-2 microglobulin (β2m), signal recogni-
tion particle 14kDa (Srp14) and succinate dehydrogenase
complex, subunit A (Sdha) and subsequently standard-
ized to E16 levels for comparison (Figure 2A, B). Four
expression level patterns emerged following analysis; 1)
very little change in levels from E16 to P30 (Hdac1), 2)
P5 and P30 levels that decreased relative to E16 (Hdacs
2, 6, and 10), P5 and P30 levels that increased relative to
E16 (Hdacs 3, 4, 5, 7, 8, 9), and levels that decreased at
P5 but increased at P30 (Hdac11).
Figure 2 mRNA expression levels in developing murine optic
nerve. RT-qPCR analysis of the relative levels of Hdac expression in
E16, P5 and P30 murine optic nerve showed that Hdac1-11 are
expressed during all stages of glial cells development studied. A and
B show the relative levels of expression for classical Hdacs in P5 and
P30 murine optic nerve relative to the levels of E16 murine optic
nerve. Bars show mean log(2) fold change ± SEM of three biological
samples per timepoint. *, p = 0.001 vs. E16; **, p≤ 0.005 vs. E16.
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are astrocytes
In order to investigate the nature of SOX2+ glial cells
within the developing murine optic nerve, sections were
double labeled using known markers for astrocytes
(PAX2) (Figure 3) and oligodendrocytes (NKX2.2)
(Figure 4) [32,33]. The majority of SOX2+ nuclei in the
developing optic nerve at E16 (Figure 3A-C), P5
(Figure 3D-F), and P30 (Figure 3G-I) showed co-
localization of SOX2 and the type I astrocyte marker,
PAX2. Quantification of the cells at all three stagesconfirmed that a large majority of SOX2+ cells co-
expressed PAX2; at E16 95% (±3%) were co-labeled,
while 96% (±2%) and 88% (±2.5%) were co-labeled at P5
and P30 respectively (Figure 3J). Counts of the number
of co-expressing cells in the proximal nerve (200μm
from the exit of the nerve from the eye) at E16, P5 and
P30 confirm the qualitative analysis of the sections
(Figure 3J) and are consistent with observations that
optic nerve astrocytes primarily populate the nerve at lo-
cations comparable to the lamina cribrosa in humans.
To examine the presence of oligodendrocyte precursors
within the developing murine optic nerve, double-label
immunohistochemistry was performed using antibodies
that recognize SOX2 and oligodendrocyte precursor
marker NKX2.2 [34]. For these experiments, we examined
two regions for co-expression of SOX2 and NKX2.2 at
P30: proximal optic nerve (up to 200μm from the exit of
the nerve from the eye) and distal optic nerve (over
200μm from the optic nerve exit). At E16 (Figure 4A-C)
and P5 (Figure 4D-F) no expression of NKX2.2 was de-
tectable in the proximal or distal optic nerve. At P30,
NKX2.2+ cells were not observed in the proximal optic
nerve (Figure 4G-I) but were present in the distal optic
nerve (Figure 4J-L). Quantification of the SOX2+ and
PAX2+ cells revealed that 16.2% of the cells within the
distal end of the optic nerve at P30 were NKX2.2+
and all of those cells showed co-localization with SOX2
(Figure 4M). These results are consistent with previous
publications showing that oligodendrocyte precursors mi-
grate into the rodent optic nerve postnatally [35].
Patterns of Protein Localization in the developing optic
nerve
To examine the temporal expression patterns and cellu-
lar localization of each HDAC in the proximal optic
nerve, western blot and double-label immunohistochem-
istry were performed. The specificity of each antibody
was tested initially by western blot analysis of proteins
isolated from mouse optic nerve (Figure 5). Each antibody
recognized a single band of the predicted molecular
weight. The bands were then quantified by densitometry
using β-TUBULIN as a loading control, and the levels of
HDACs at each stage were graphed relative to E16 levels.
Densitometric analysis indicated that the levels of a major-
ity of HDACs were higher at E16, with falling levels at P5
and P30 (Figure 5). Protein levels showed temporal
changes in expression corresponding to mRNA levels for
most of the HDACs. Two exceptions to this observation
were HDAC3 and 11. In the case of HDAC3, the mRNA
decreased with developmental stage, whereas the protein
levels increased. HDAC11 RNA increased substantially at
P30, whereas the protein levels decreased. In addition, be-
cause RT-qPCR detected Hdac7mRNA in the optic nerve,
we attempted to analyze HDAC7 protein expression in
Figure 3 PAX2 and SOX2 localization pattern in developing murine optic nerve. Optic nerve sections at E16 (A-C), P5 (D-F) and P30 (G-I) were
triple-labeled with DAPI (blue), PAX2 (green) and SOX2 (red). An overlay of PAX2 and DAPI (A, D, G) is shown to aid in orientation of the images.
Immunolabel of SOX2 and PAX2 (arrows) showed a majority of cells to be colabeled at all stages examined. Composite images in C, F and I show z
stacks of optic nerve; horizontal yellow lines correspond the x axis plane and vertical yellow lines corresponds to the y axis. The x, z axis is shown at
the bottom of each panel, while the y, z axis is shown to the right of the panel. Graph shown (J), represents the percentage of cells positively labeled
for SOX2 alone, PAX2 alone or SOX2 and PAX2 together in the proximal optic nerve. Bars show mean ± SEM of three samples per timepoint.
Abbreviations: R; retina, ON; optic nerve. Scale bars = 50 μm. Scale bar in C applies to A-I.
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tested were specific by western blot, precluding meaning-
ful analysis of HDAC7 protein expression.
To determine the cellular distribution of each HDAC
in the developing optic nerve glia, sections of murine
optic nerve and nerve head were double-labeled withSOX2 and antibodies specific for each HDAC. The ana-
lysis of HDAC immunoreactivity in the optic nerve re-
vealed 3 basic patterns: 1) predominantly nuclear, 2)
nuclear and cytoplasmic, or 3) cytoplasmic (see Table 1).
Examples of each of the localization patterns are shown
in Figures 6, 7, and 8, whereas the rest of the localization
Figure 4 NKX2.2 and SOX2 localization in developing murine optic nerve. Optic nerve sections at E16 (A-C), P5 (D-F), P30 proximal to the
eye (G-I) and P30 distal to the eye (J-L), were triple-labeled with DAPI (blue), SOX2 (green) and NKX2.2 (red). An overlay of NKX2.2 and DAPI is
shown to aid in orientation of the images (A, D, G, J). At E16 and P5, NKX2.2+ cells were not detected in the proximal or distal optic nerve
(B, E). At P30, NKX2.2+ cells were not detected in the proximal nerve (H), but were found in the distal optic nerve (K). Composite images in
C, F, I and L show z stacks of labeled optic nerve; horizontal yellow lines correspond the x axis plane and vertical yellow lines corresponds to the
y axis. The x, z axis is shown at the bottom of each panel, while the y, z axis is shown to the right of the panel. Graph shown (M), represents the
percentage of cells positively labeled for SOX2 alone, NKX2.2 alone or both SOX2 and NKX2.2 together. Bars show mean ± SEM of three samples
per timepoint. Abbreviations: R; retina, ON; optic nerve. Scale bars = 50 μm. Scale bar in C applies to A-L.
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file 1: Figure S1, Additional file 2: Figure S2, Additional
file 3: Figure S3, Additional file 4: Figure S4, Additional file 5:
Figure S5, Additional file 6: Figure S6 and Additional
file 7: Figure S7).HDACs 1 and 2 were predominantly nuclear in localiza-
tion at all timepoints examined (Figure 6 and Additional
file 1: Figure S1). In both cases, there was a high degree of
overlap between SOX2+ nuclei and HDAC1 or HDAC2
immunoreactivity. However, at E16, there were also clearly
Figure 5 Expression of HDACs in murine optic nerve. Western blot analysis of HDAC proteins in E16, P5 and P30 murine optic nerve was
performed to check the specificity of the antibodies used for the study. Blots were normalized to β-TUBULIN. Densitometric graphs for each HDAC
panel show quantification of protein levels expressed as fold-change from E16. p < 0.05 was considered statistically significant and represented by a
single *, whereas p < 0.005 is represented by **. Bars show mean ± SEM of three samples per timepoint. Note that the apparent increase in band
intensities for some P5 samples (e.g. HDAC2, 3 and 4) reflect increased protein loading in those lanes.







E16 1, 2 3, 5 4, 6, 8, 9, 10, 11
P5 1, 2 5, 6, 8, 11 3, 4, 9, 10
P30 1, 2 5, 8 3, 4, 6, 9, 10, 11
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no HDAC1 labeling (arrowheads, Figure 6E). There were
also HDAC1 and HDAC2 + cells present within the optic
nerve that were SOX2-negative. Since SOX2 is a marker
of glial cells, HDAC+/SOX2-negative cells within the
optic nerve itself were presumably endothelial cells or
pericytes that are associated with blood vessels within the
optic nerve.
HDACs 3, 5, 6, 8 and 11 were predominantly cytoplas-
mic, but showed nuclear co-labeling with SOX2 at one
Figure 6 HDAC1 localization pattern in developing murine optic nerve. (A) Low magnification confocal micrograph showing the P30 optic
nerve (ON), optic nerve head and retina (R) double-labeled for SOX2 (glia, green) and HDAC1 (red). Optic nerve sections at E16 (B-E), P5 (F-I) and
P30 (J-M) were triple-labeled with DAPI (blue), SOX2 (green) and HDAC1 (red). (B, F, J) Overlay of SOX2 and DAPI to aid in orientation of the
image. Subsequent panels did not include DAPI to better show the co-localization of the SOX2 and HDAC labels. (C, G, K) HDAC1; (D, H, L)
double-label of SOX2 and HDAC1. Arrows indicate nuclei that were co-labeled with SOX2 and HDAC1. Composite images in E, I and M show z
stacks of optic nerve at high magnification; horizontal yellow lines correspond the x axis plane and vertical yellow lines corresponds to the y axis.
The x, z axis is shown at the bottom of each panel, while the y, z axis is shown to the right of the panel. Negative controls at each stage showed
absence of immunoreactivity following preabsorption of antibodies with the corresponding peptide immunogen (N-P). Abbreviations: R; retina,
ON; optic nerve. Scale bars = 50 μm. Scale bar in B applies to B-D, F-H, and J-L, scale bar in E applies to E, I and M.
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file 1: Figure S2, Additional file 3: Figure S3 and Additional
file 4: Figure S4 and Additional file 7: Figure S7). HDAC3
was co-localized with SOX2 in nearly all nuclei within the
laminar region at E16, but only a few SOX2+ nuclei were
also HDAC3+ at P5 and none of the SOX2+ nuclei were
HDAC3+ at P30 (Figure 7). HDAC5 (Additional file 2:Figure S2) and HDAC 11 (Additional file 7: Figure S7)
were rarely detected SOX2+ nuclei at P5 and those that
were detected were located primarily near the outermost
edge of the optic nerve. HDAC6 was co-localized with
SOX2 in the laminar glia at P5 (Additional file 3: Figure S3),
but was not detected in glia at other timepoints. HDAC8
(Additional file 4: Figure S4) was detected in a few SOX2+
Figure 7 HDAC3 localization pattern in developing murine optic nerve. (A) Low magnification confocal micrograph showing the P30 optic
nerve (ON), optic nerve head and retina (R) double-labeled for SOX2 (green) and HDAC3 (red). Optic nerve sections at E16 (B-E), P5 (F-I) and P30
(J-M) were triple-labeled with DAPI (blue), SOX2 (green) and HDAC3 (red). (B, F, J) Overlays of SOX2 and DAPI to aid in orientation of the image.
Subsequent panels did not include DAPI to better show the co-localization of the SOX2 and HDAC3 labels. (C, G, K) HDAC3; (D, H, L) double-label of
SOX2 and HDAC3. Arrows indicate nuclei that were co-labeled with SOX2 and HDAC3. Composite images in E, I and M show z stacks of optic nerve at
high magnification; horizontal yellow lines correspond the x axis plane and vertical yellow lines corresponds to the y axis. The x, z axis is shown at the
bottom of each panel, while the y, z axis is shown to the right of the panel. Negative controls at each stage showed a lack of immunoreactivity
following preabsorption of antibodies with the peptide immunogen (N-P). Abbreviations: R; retina, ON; optic nerve. Scale bars = 50 μm. Scale bar
in B applies to B-D, F-H, and J-L, and scale bar in E applies to E, I and M.
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the more proximal regions of the optic nerve at P5 and
P30. There was HDAC immunoreactivity in the optic
nerve that was not localized to the nuclei and was there-
fore presumed to be cytoplasmic. Given the extensive
non-nuclear staining for HDACs 3, 5, 6, 8 and 11, it is
possible that some of the apparent co-localization was a
result of overlap between their cytoplasmic staining and
the nuclear SOX2 immunoreactivity. However, confocal
imaging showed co-localization of SOX2 and the HDACsin both the x/z and y/z planes supporting at least some
nuclear localization.
HDACs 4, 9, and 10 were predominantly cytoplasmic,
with little to no nuclear label evident at any stage of de-
velopment (Figure 8 and Additional file 5: Figure S5 and
Additional file 6: Figure S6). For HDAC10, the apparent
double labeling observed in low magnification image
(Additional file 6: Figure S6) was an artifact that was not
supported when examined at higher magnification using
confocal imaging.
Figure 8 HDAC4 localization pattern in developing murine optic nerve. (A) Low magnification confocal micrograph showing the P30 optic
nerve (ON), optic nerve head and retina (R) double-labeled for SOX2 (green) and HDAC4 (red). Optic nerve sections at E16 (B-E), P5 (F-I) and P30
(J-M) were triple-labeled with DAPI (blue), SOX2 (green) and HDAC4 (red). (B, F, J). Overlays of SOX2 and DAPI to aid in orientation of the image.
Subsequent panels did not include DAPI to better show the co-localization of the SOX2 and HDAC3 labels. (C, G, K) HDAC4; (D, H, L) double-label of
SOX2 and HDAC4. Composite images in E, I and M show z stacks of optic nerve at high magnification; horizontal yellow lines correspond the x
axis plane and vertical yellow lines corresponds to the y axis. The x, z axis is shown at the bottom of each panel, while the y, z axis is shown to
the right of the panel. Negative controls at each stage showed a lack of immunoreactivity following preabsorption of antibodies with the peptide
immunogen (N-P). Abbreviations: R; retina, ON; optic nerve. Scale bars = 50 μm. Scale bar in B applies to B-D, F-H, and J-L. Scale bar in E applies
E, I and M.
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Summary
To summarize the findings of these studies: 1) HDACs
1–11 were expressed in the optic nerve glial cells at all
three stages of optic nerve development in the mouse, 2)
HDACs 1 and 2 were predominantly nuclear throughout
optic nerve development and glial cell maturation, 3)
HDACs 3, 5, 6, 8,11 were predominantly cytoplasmicbut showed nuclear localization in at least one stage of
optic nerve development, 4) HDACs 4, 9 and10 were
predominantly cytoplasmic, with little to no nuclear ex-
pression at any time during the developmental stages ex-
amined, and 5) nuclei co-labeled for AcH3K18 and
MeH3K9 were present at similar levels throughout optic
nerve development. In interpreting these data, we propose
that both acetylation and deacetylation are required for
Tiwari et al. BMC Developmental Biology 2014, 14:30 Page 11 of 18
http://www.biomedcentral.com/1471-213X/14/30astrocyte development within the optic nerve head and
glial lamina. In light of the observation that HDACs 1, 2,
3, 5, 6, 8, and 11 were all co-localized to SOX2+ nuclei at
some stages of development, these HDACs would be good
candidates for further study to determine which interact
with nuclear histones to regulate chromatin organization.
Our finding that HDAC2 is predominately nuclear in
cells within the optic nerve differs from a recent report
showing immunoreactivity for HDAC2 throughout the
optic nerve in the nuclei of resident cells and the cyto-
plasm of the axons [36]. A major difference between the
two studies is the ages of animals analyzed: in our devel-
opmental analysis, P30 was the latest age analyzed,
whereas the other study analyzed expression in 12
month old mice. There were also regional differences in
the portions of the optic nerve analyzed. In the present
study, the area of the optic nerve head and glial lamina
was analyzed, whereas in the previous report, the
morphology of the nuclei would be more consistent with
the non-laminar regions of the optic nerve closer to the
optic chiasm. The non-laminar portions of the optic
nerve contain the progeny of the oligodendrocyte pre-
cursors, whereas the laminar astrocytes are thought to
derive from the intrinsic PAX2 expressing astrocyte pre-
cursors [5,29]. Therefore, the differences in HDAC2 ex-
pression could reflect the different lineages of the glial
cells present in these distinct regions of the optic nerve.
In addition, different antibodies were used, which could
contribute to different patterns of immunoreactivity. It
remains to be determined if these differences represent
age-related or lineage-related changes in distribution of
HDAC2. Interestingly, the patterns of HDAC1 and HDAC3
in the aging optic nerve appeared similar to that observed
at P30 in our study, despite the differences in age, location
within the optic nerve and in the primary antibodies used.
Many of the HDACs also appear to be localized to the
cytoplasm in addition to or instead of the nucleus. The
nuclear import of HDACs is blocked by post-translational
modification or cleavage [37-44], therefore, the cytoplas-
mic localization of some HDACs reflects regulated protein
trafficking between cellular compartments. In addition,
HDACs have also been shown to deacetylate non-histone
proteins resulting in changes in their structural and func-
tional characteristics. For instance, HDAC6 interacts with
cytoplasmic proteins such as tubulin and chaperones such
as heat shock proteins (Hsp90), causing changes in the
contractile functions of the muscles. Similarly, HDAC8
can deacetylate heat shock protein 20 (Hsp20) in the myo-
metrium [45,46]. Hence the cytoplasmic localization of
some HDACs may reflect an additional role for HDACs in
deacetylation of cytoplasmic proteins during glial differen-
tiation and maturation.
Protein levels showed temporal changes in expression
that corresponded to mRNA levels for most of theHDACs consistent with general regulation at the tran-
scriptional level. Two exceptions to this observation
were HDACs 3 and 11, which showed increased mRNA
levels at timepoints where protein levels were substan-
tially decreased. Many factors can influence the conver-
sion of mRNA into proteins including mRNA and/or
protein half-life, post transcriptional regulation by micro
RNAs [47,48]. HDACs are well-known targets of post-
translational modifications that can affect their stability
and activity, such as proteasome degradation via ubiqui-
tinases or caspase mediated cleavage [49-52]. The E3
ubiquitin ligase SIAH2 interacts directly with HDAC3
and targets it for ubiquitin-dependent proteosomal deg-
radation [53]. Although mechanisms regulating HDAC11
expression have not been characterized, there are reports
of non-congruent changes in mRNA and protein levels in
the murine brainstem and diencephalon at later stages of
postnatal development [54]. Interestingly, in at least one
study, HDAC4 mRNA was shown to have a much shorter
half-life in comparison to the protein, leading differential
increases in protein expression relative to mRNA levels
[49]. Together, these findings are consistent with regula-
tion of at least some HDACs at both transcriptional and
post-transcriptional levels.
Cells in the developing optic nerve do not appear to be
globally acetylated or deacetylated
Several studies have concluded that the genome of differ-
entiating neurons is globally acetylated [30,55], whereas
other studies have proposed that acetylation is the key to
the differentiation of oligodendrocytes [54,56-61]. In non-
neuronal cells including glia, recruitment of HDACs by
the RE-1 silencing transcription factor (REST) to the pro-
moter of neuronal genes is critical to repress these genes
and is thought to be essential for the development of glial
cells [62-64]. Some of our data is consistent with the idea
that deacetylation contributes to differentiation of astro-
cytes within the optic nerve head and laminar regions of
the optic nerve; we found seven of the classic HDACs (1,
2, 3, 5, 6, 8, 11) are present in the nuclei of SOX2 positive
glia in at least one or more stages during the astrocyte dif-
ferentiation, consistent with a potential role in chromatin
regulation. We did not examine the localization of
HDAC7 due to lack of a sufficiently specific antibody, or
expression of the sirtunins, the Class III HDACs. There-
fore additional HDACs may be expressed in the glial pre-
cursors and differentiated cells that are not described in
this study.
Many of the previous studies have focused on HDACs
1, 2, or 11 during differentiation of oligodendrocytes
[54,59,65]. In contrast, very few studies have studied the
role of epigenetics in astrocyte differentiation, but those
that have been done appear to have conflicting results.
Several studies using siRNA and morpholino antisense
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HDAC1 and 2, alters differentiation of both oligoden-
drocytes and neurons, without changing the number of
astrocytes [30,31,61,66,67]. A region-specific role for
HDACs has been identified in the telencephalon, inhib-
ition of HDAC activity resulted in a BMP mediated de-
crease in neurogenesis and increase in astrogliogenesis
by progenitors arising from the ganglionic eminences of
the telencephalon in vivo and in vitro [68]. Further sup-
porting a role in gliogenesis is the discovery that acetyl-
ation of histones associated with the STAT3 binding
element in the GFAP promoter, a gene expressed typic-
ally in mature astrocytes, allows the LIF/STAT3 pathway
to upregulate expression of GFAP [69]. Likewise, micro-
array analysis of neurosphere culture of forebrain cells
treated with trichostatin A (to inhibit histone deacetyla-
tion) and BMP- (to promote astroglial differentiation)
in vitro showed that STAT3 and phospho-STAT3, down-
stream members of the LIF and BMP pathways, were
upregulated [70,71]. However, in the developing cortex
in rats, neurogenesis was enhanced by HDAC inhibition
in vivo, showing that there are regional and possibly
lineage-specific differences in the functional contribu-
tions of HDAC activity to the neuronal/glial switch [68].
Some of the disparities in the studies of HDACs and as-
trocytes may be attributable to the fact that both in vitro
and in vivo experiments are being compared. Epigenetic
factors are regulated by cellular microenvironment and
placing the cells in vitro has traditionally been a means
of testing the effects of changing microenvironment on
the cells. Therefore it should not come as surprise that
epigenetic factors change when the cells are removed
from the “normal” in vivo microenvironment.
The study presented here provides an excellent start-
ing point for investigating the role of histone acetylation
and deacetylation in optic nerve development and dis-
ease. Our data are consistent with contributions by not
only HDAC1 and 2, but other HDACs that have not yet
been actively studied. In addition to deacetylation, we
also infer that acetylation is an intrinsic component to
the differentiation of the laminar astrocytes. This is
based on our finding that at all the three stages exam-
ined, antibodies specific for acetylated histone 3 immu-
nolabeled increasing numbers of cells with increasing
intensity across development. Whereas the studies
herein are consistent with HDACs and HATs acting in
combination to bring about macroglial differentiation,
future studies will examine the roles of various HDACs
and HATs at the genome level to ascertain their function
at specific loci.
Interestingly, several studies have reported that sys-
temic inhibition of HDAC activity can reduce RGC loss
following injuries such as optic nerve crush [72,73], is-
chemia [36] and in the Dba/2J mouse model of pigmentdispersion glaucoma [74]. However, an as yet unanswered
question is how much of the rescue reflects direct effects
on histone acetylation in retinal ganglion cells and how
much is attributable to effects on the glial populations in
the retina and/or optic nerve. Future studies will focus on
testing the role of specific HDACs in glial cell develop-
ment within the optic nerve and retina, as well as investi-
gating potential changes in expression or activity levels in
retinal diseases.
Conclusion
The results of this study show that all the classical
HDACs are present in the astrocytes during different
stages of murine optic nerve development. Based on the
localization pattern, the classical HDACs were placed
into one of three different categories; predominantly nu-
clear, nuclear and cytoplasmic, and predominantly cyto-
plasmic. Seven of the classical HDACs, namely 1, 2, 3, 5,
6, 8, and 11, were localized to the nuclei of SOX2 posi-
tive glial cells in at least one or more stages of astrocyte
differentiation in the murine optic nerve. HDACs 4, 9,
and 10 were predominantly cytoplasmic throughout the
development of the optic nerve astrocytes. Finally,
HDAC7 was found in the optic nerve by RT-qPCR, but
an antibody specific for HDAC7 was not available, hence
the expression pattern of HDAC7 could not be deter-
mined. Understanding the localization pattern of HDACs
during different stages of development of murine optic
nerve provides a valuable resource to study the role of epi-
genetic regulation in the differentiation of the glial cell
types, an area that has not been yet fully explored. Further,
our data also provides an important avenue of future re-
search, for understanding the potential role of epigenetic
changes associated with disease processes such as glau-
coma and diabetes.
Methods
Animal husbandry and tissue collection
Animals in this study were obtained and cared for in ac-
cordance with the Association for Research in Vision
and Ophthalmology (ARVO) statement for the use of
animals in ophthalmic and vision research and were
housed in an AAALAC accredited housing facility in the
School of Science on a 12 hour (hr) light/dark cycle. The
ethical treatment of animals used for this study was ap-
proved by the IUPUI Science Animal Resource Center
(protocol SC194R).
C57BL/6J mice were obtained from Jackson Labs (Bar
Harbor, ME). For embryonic stages, mice were mated
overnight and the females checked for vaginal plugs the
next morning. The date the vaginal plug was detected
was designated 0.5 days post coitum. At embryonic day
16 (E16), heads were removed and fixed in 4% parafor-
maldehyde in 0.1M phosphate buffer, pH 7.4 at 4°C for
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in 4% paraformaldehyde in 0.1M phosphate buffer,
pH7.4 at 4°C for 2 hrs. Following fixation, eyes were
rinsed twice in 1X phosphate buffered saline (PBS; po-
tassium chloride 200 mg/L, potassium phosphate 200
mg/L, sodium chloride 8000 mg/L, and sodium phos-
phate 1150 mg/L), pH 7.5 and placed in a graded series
of sucrose in 0.1M phosphate buffer, starting at 5% and
ending with 20%. Eyes were frozen in a 3:1 ratio of 20%
sucrose in 0.1M phosphate buffer to Optimal Cutting
Temperature (OCT; Sakura FineTek USA, Inc.) solution
and stored at −80°C until sectioned.
Immunohistochemistry
Ten micron sections were cut with a cryostat (Leica
CM3050 S), placed on charged glass slides (Superfrost
Plus; Fisher Scientific, Pittsburgh, PA), and stored at −80°C
until used for immunohistochemistry. Slides were re-
moved from the freezer, allowed to warm at room
temperature for 30–40 minutes (min), liquid blocker ap-
plied to the regions surrounding the sections, and sections
were post-fixed with 4% paraformaldehyde for 30 min at
room temperature. Slides were washed in 1XPBS (2 × 2
min), incubated with methanol for 10 min at room
temperature and washed twice with 1XPBS for (2 × 2
min). Antigen retrieval was performed by incubating sec-
tions in 1.0% SDS in 1XPBS for 5 min at room
temperature. Slides were washed three times in 1XPBS
(3 × 5 min) at room temperature, followed by treatment
with 1.0% sodium borohydride for two min at roomTable 2 Concentration of antibodies used for IHC and Wester
Antibody Source
Rabbit Anti-HDAC1 (Cat # ab33278) ABCAM (Cambridge, MA)
Mouse Anti-HDAC2 (Cat # ab12169) ABCAM (Cambridge, MA)
Rabbit Anti-HDAC3 (Cat # ab16047) ABCAM (Cambridge, MA)
Mouse Anti-HDAC4 (Cat# NBP2–22151) Novus Biologicals (Littleton
rabbit Anti-HDAC5 (Cat # ab53693) ABCAM (Cambridge, MA)
Goat Anti PAX2 (Cat # AF3364) R and D Systems (Minneap
Rabbit Anti HDAC6 (Cat # LS-B5253) Life Span Biosciences (Seat
Rabbit Anti-HDAC8 (Cat # LS-B967) Life Span Biosciences (Seat
Rabbit Anti-HDAC9 (Cat # ab59718) ABCAM (Cambridge, MA)
Rabbit Anti-HDAC10 (Cat # NB100-91801) Novus Biologicals (Littleton
Rabbit Anti-HDAC11 (Cat # ab18973) ABCAM (Cambridge, MA)
Mouse Anti NKX2.2 (Cat # 74.5A5-s) Developmental Hybridoma
Mouse Anti-methylated histone (cat # ab1220) ABCAM (Cambridge, MA)
Rabbit Anti-Acetylated lysine (Cat # 9441) Cell Signaling (Danvers, MA
Goat Anti-SOX2 (Cat # sc17320) Santa Cruz (Santa Cruz, CA
Mouse Anti SOX2 (Cat # ab75485 ABEAM (Cambridge, MA)
Mouse anti-β-tubulin (Cat # T0198) SIGMA (St. Louis, MO)temperature to reduce autofluorescence. After removal
of the sodium borohydride, sections were blocked with
blocking solution (5% bovine serum albumin, 10% don-
key serum, 0.25% triton X-100 in 1X Hanks balanced
salt solution (HBSS) for 2 hrs at room temperature. Fol-
lowing removal of blocking solution, primary antibodies,
diluted in 2% serum in 0.025% triton X, were added and
incubated overnight at 4°C in a humid chamber. Dilu-
tions and sources of each antibody are in Table 2.
Slides were then washed the next day in 1XPBS (2 ×
10 min) at room temperature and were then incubated
with secondary antibodies [Alexa-fluor conjugated sec-
ondaries (Donkey anti rabbit 549 and Donkey anti goat
488) from Invitrogen and DyLight conjugated secondar-
ies (Donkey anti mouse 546) from Jackson ImmunoRe-
search] dissolved in 1XPBS at 1:800 dilution for 1 hr in
dark at room temperature. Secondary antibodies were
removed by washing the slides in 1XPBS (2 × 10 min).
Sections used to label NKX2.2, the marker used for oli-
godendrocytes, were treated with biotinylated secondary
antibody (BA9200, Vector laboratories) for 1 hr and then
washed with 1XPBS (2X10 min). Incubation with Strep-
tavidin 549 (SA-5549, Vector Laboratories) was then
performed for 1 hr. Sections were mounted with anti-
fade mounting medium containing DAPI (Prolong gold,
Life Technologies). In some experiments, antibodies
were preabsorbed with 32 μg/ml of the peptide or pro-
tein immunogen that was used to generate the anti-
bodies for 1 hr prior to incubation with sections and
immunofluorescence performed as usual. Additionalns
Antibody dilution Peptide supplier
IHC Westerns
1:300 1:2500 Abcam (Cambridge, MA)
1:350 1:2500 Abcam (Cambridge, MA)
1:300 1:2500 Abcam (Cambridge, MA)
, Co) 1:100 1:1500 Abcam (Cambridge, MA)
1:100 1:750 Abcam (Cambridge, MA)
olis, MN) 1:100 N/A R and D Systems (Minneapolis, MN)
tle, WA) 1:250 1:1000 Santa Cruz (Santa Cruz, CA)
tle, WA) 1:500 1:750 Life Span Biosciences
1:250 1:500 Abcam (Cambridge, MA)
, Co) 1:100 1:500 Santa Cruz (Santa Cruz, CA)
1:100 1:200 Abcam (Cambridge, MA))
1:10 N/A N/A
1:300 N/A N/A
) 1:100 1:2000 N/A
) 1:250 N/A Santa Cruz (Santa Cruz, CA)
1:100 N/A Abcam (Cambridge, MA))
N/A 1:1000 N/A
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ing solution in place of the primary antibody and im-
munofluorescence performed as usual. Negative controls
peptides corresponding to each HDAC are shown in
Table 2. For all immunohistochemistry analysis, at least
3 independent samples were examined for antibody at
each stage. Immunolabeling was imaged using an Olym-
pus Fluoview FV 1000 confocal microscope. For Z stack
images, an average of 22 to 25 optical sections were
taken and merged together.
Tissue analysis using cell counts
Confocal images of sections co labeled with SOX2 and
PAX2, SOX2 and NKX2.2 were taken using FV1000
Olympus Fluoview microscope. Cells showing positive
label in the optic nerve were counted over an area ofTable 3 List of primers used in RT-qPCR
Gene Accession
number
Primer Sequence (5′ to 3′)
Hdac1 NM_008228.2 Forward TGGGGCTGGCAAAGGCAA
Reverse GACCACTGCACTAGGCTGGA
Hdac2 NM_ 008229.2 Forward CGTACAGTCAAGGAGGCGG
Reverse TGAGGCTTCATGGGATGACCC
Hdac3 NM_010411.2 Forward ACGTGCATCGTGCTCCAGT
Reverse AGTGTAGCCACCACCTCCCA
Hdac4 NM_207225.1 Forward AGCTCTGGCAACGTCAGCA
Reverse AAGTGGGGCGACTGAGCCT
Hdac5 NM_001077696.1 Forward ACGTAAATGTGGCGTGGACA
Reverse TTCAACAGCATCAAACCCAGC
Hdac6 NM_010413.3 Forward TGGGGCTTCAAGGGCTGGA
Reverse TGCTCTCTGATGGCATGGAG
Hdac7 NM_001204275.1 Forward GCTCAGCATGTGCATGTGGAA
Reverse TGAGAGCCTGGTGTGTCTGG
Hdac8 NM_027382.3 Forward ATGACACCAGTGGTCGGC
Reverse ACGAGCCGTGTTGGCAAGG
Hdac9 NM_024124.3 Forward TGCACCTTTGCCTCAGAGCA
Reverse TGGCTGCCTGGTTGCTTCA
Hdac10 NM_199198.2 Forward TAGCAGCCAAACATGCCAAG
Reverse ATGCTCATAGCGGTGCCAAGA
Hdac11 NM_144919.2 Forward GCTGGGAAATGGGGCAAGG
Reverse AGCTCGTTGAGATAGCGCCT
Sdha NM_023281.1 Forward GGACAGGCCACTCACTCTT
Reverse CACAGTGCAATGACACCA
Srp14 NM_009273.4 Forward TCGAGCCCGCAGAAAAC
Reverse CTCTTCTTCAGCCCGTCCA
β2-Microglobulin NM_009735.3 Forward TCGCGGTCGCTTCAGTCGT
Reverse CATTCTCCGGTGGGTGGCG200 μm at all three stages (E16, P5 and P30) using retina
on both sides as a reference. Cells were counted in every
third section of through the optic nerve and three differ-
ent nerves were analyzed for each timepoint.
RT-qPCR
Optic nerves from the exit of the optic nerve up to, but
not including the optic chiasm, were quickly isolated
from mice following euthanasia and preserved in RNA
stabilizing agent (RNAlater; Qiagen; Cat # 76104) at 4°C
until ready for total RNA extraction. Total RNA was iso-
lated using affinity columns (High Pure RNA Tissue Kit,
Roche; Cat # 12033674001) with DNAse treatment. Qual-
ity analysis and quantification of total RNA was done
using Nanodrop 2000c (ThermoScientific). For each RNA











GT 133 −3.586 ±0.588 95.0% ±0.200 −0.996
ACA
CAA 97 −3.361 ±0.551 99.0% ±0.223 −0.996
TGG
GT 150 −3.416 ±0.42 98.0% ±0.163 −0.997
GT
CT 114 −3.347 ±0.631 99.5% ±0.258 −0.993
TCT
GGA 147 −3.227 ±0.264 102.0% ±0.119 −0.999
GGA
TCT 148 −3.098 ±0.380 105.0% ±0.192 −0.997
CC
CAC 132 −3.276 ±0.520 101.0% ±0.226 −0.995
CT
AA 105 −3.263 ±0.656 101.5% ±0.288 −0.994
TT
CG 150 −3.373 ±0.239 99.0% ±0.096 −0.999
GT
CAGA 143 −3.289 ±0.329 100.5% ±0.0131 −0.998
GAAA
TGA 134 −3.125 ±0.728 104.5% ±0.358 −0.992
CGT
AC 130 −3.493 ±0.496 96.5% ±0.181 −0.997
CG
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8891; Biorad). Briefly, cDNA was reverse transcribed by
incubating 1μg of RNA template with nuclease-free water,
1X buffer reaction mix and reverse transcriptase at 25°C
for 5 min, 42°C for 20 min, and 85°C for 5 min. cDNA
was stored at −20°C until used for PCR reactions. Primer
pairs (Table 3) were designed to detect all splice variants
and spanned at least one intron. Specificity was verified
using in silico PCR on the Santa Cruz Genome Browser
[http://genome.ucsc.edu/], build mm10 [75]. Primer pairs
for Hdac1 also recognized a pseudogene located on
chromosome X, but did not amplify in RT-minus reac-
tions. Quantitative PCR reactions were processed in the
investigator’s laboratory using Applied Biosystems Real
Time PCR System (Model # 7300) in triplicate 20 μl reac-
tions using SYBR green chemistry (Power SYBR Green
Cat # 4368706; Applied Biosystems) according to manu-
facturer’s protocol with final primer concentration of 1μm
and 4 μl of a 1:20 dilution of cDNA used in each reaction.
Cycling conditions were: initial denaturation at 95°C for
10 min, 40 cycles of 95°C for 15 seconds (sec), 60°C for
30 sec, and 72°C for 30 sec, and a final extension of
72°C for 5 min. Melting curve analysis was performed
with each PCR to verify single products were generated.
Efficiency of each primer set was tested using the
standard curve method: E = ((10(−1/slope)-1) X 100, where
E = efficiency. Three reference genes, β-2 microglobulin
(B2m), signal recognition particle 14 kDa (Srp14) and
succinate dehydrogenase complex, subunit A (Sdha),
were selected based on their reported consistent expres-
sion levels during rat retinal development [76] and in
microarray data of gene expression during mouse eye
and optic nerve development using the publicly avail-
able RefGene database [http://www.refgenes.org/rg/] [77].
Crossing thresholds (Ct) were determined by crossing
point analysis (Additional file 8: Table S1). Data analysis
and comparison of relative quantities used Relative Ex-
pression Software Tool-Multiple Condition Solver (REST-
MCS, [http://www.gene-quantification.de]) using the three
reference genes for normalization [78]. This method uses
a mathematical model that includes efficiency corrections
and mean crossing-point deviation between the sample
groups and control groups, with expression ratios tested
for significance using a pair-wise fixed reallocation ran-
domization test (2000 iterations); p ≤ 0.05 was considered
statistically significant.
SDS-PAGE and western analysis
Isolated optic nerve tissue samples were lysed using lysis
buffer (5M NaCl, 1M Tris pH 8.0, 0.5 M EDTA, 5%
Triton-X 100 supplemented with protease inhibitor
cocktail (Cat # P50700, RPI Corp) and 1 mM PMSF (Cat #
10837091001, Roche) on ice. Tissue lysates were centri-
fuged at 14000 rpm for 10 min at 4°C and supernatantwas collected. Total protein concentration was deter-
mined using BCA protein Assay reagent (ThermoScienti-
fic). Proteins were resolved using SDS-PAGE (4-20%
gradient gel), transferred to PVDF membranes, and
blocked using 5% milk or protein-free tween 20 buffer (cat
# 37571; ThermoScientific) and immunoblotted using spe-
cific HDAC antibodies. The concentrations of antibodies
employed are specified in Table 2. The blots were stripped
and re-probed for β-tubulin to check for equal protein
loading. Densitometric analyses of the blots were per-
formed using ImageJ 1.43u software Statistics was per-
formed on the densitometric data using a one-way
ANOVA with F-test and Scheffe procedure used for post
hoc comparisons, with p < 0.05 considered statistically sig-
nificant (IBM SPSS Statistics 20 software).Additional files
Additional file 1: Figure S1. HDAC2 localization pattern in developing
murine optic nerve. (A) Low magnification confocal micrograph showing
the P30 optic nerve (ON), optic nerve head and retina (R) double-labeled
for SOX2 (glia, (green) and HDAC2 (red). Optic nerve sections at E16 (B-E),
P5 (F-I) and P30 (J-M) were triple-labeled with DAPI (blue), SOX2 (green)
and HDAC2 (red). (B, F, J) Overlays of SOX2 and DAPI to aid in orientation
of the image. Subsequent panels did not include DAPI to better show
the co-localization of the SOX2 and HDAC2 labels. (C, G, K) HDAC2; (D, H, L)
double-label of SOX2 and HDAC2. Arrows indicate nuclei that were
co-labeled with SOX2 and HDAC2. Composite images in E, I and M show z
stacks of optic nerve at high magnification; horizontal yellow lines
correspond the x axis plane and vertical yellow lines corresponds to the y
axis. The x,z axis is shown at the bottom of each panel, while the y,z axis is
shown to the right of the panel . Negative controls at each stage showed a
lack of immunoreactivity following preabsorption of antibodies with the
peptide immunogen (N-P). Abbreviations: R; retina, ON; optic nerve. Scale
bars = 50 μm. Scale bar in B applies to B-D, F-H, and J-L, scale bar in E
applies to E, I and M.
Additional file 2: Figure S2. HDAC5 localization pattern in developing
murine optic nerve. (A) Low magnification confocal micrograph showing
the P30 optic nerve (ON), optic nerve head and retina (R) double-labeled
for SOX2 (glia, (green) and HDAC5 (red). Optic nerve sections at E16 (B-E),
P5 (F-I) and P30 (J-M) were triple-labeled with DAPI (blue), SOX2 (green)
and HDAC5 (red). (B, F, J) Overlays of SOX2 and DAPI to aid in orientation
of the image. Subsequent panels did not include DAPI to better show
the co-localization of the SOX2 and HDAC5 labels. (C, G, K) HDAC5; (D, H, L)
double-label of SOX2 and HDAC5. Arrows indicate nuclei that were
co-labeled with SOX2 and HDAC5. Composite images in E, I and M show z
stacks of optic nerve at high magnification; horizontal yellow lines
correspond the x axis plane and vertical yellow lines corresponds to the y
axis. The x,z axis is shown at the bottom of each panel, while the y,z axis is
shown to the right of the panel. Negative controls at each stage showed a
lack of immunoreactivity following preabsorption of antibodies with the
peptide immunogen (N-P). Abbreviations: R; retina, ON; optic nerve. Scale
bars = 50 μm. Scale bar in B applies to B-D, F-H, and J-L, scale bar in E
applies to E, I and M.
Additional file 3: Figure S3. HDAC6 localization pattern in developing
murine optic nerve. (A) Low magnification confocal micrograph showing
the P30 optic nerve (ON), optic nerve head and retina (R) double-labeled
for SOX2 (glia, (green) and HDAC6 (red). Optic nerve sections at E16 (B-E),
P5 (F-I) and P30 (J-M) were triple-labeled with DAPI (blue), SOX2 (green)
and HDAC6 (red). (B, F, J) Overlays of SOX2 and DAPI to aid in orientation
of the image. Subsequent panels did not include DAPI to better show
the co-localization of the SOX2 and HDAC6 labels. (C, G, K) HDAC6; (D, H, L)
double-label of SOX2 and HDAC6. Arrows indicate nuclei that were co-
labeled with SOX2 and HDAC6. Composite images in E, I and M show z
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http://www.biomedcentral.com/1471-213X/14/30stacks of optic nerve at high magnification; horizontal yellow lines
correspond the x axis plane and vertical yellow lines corresponds to the y
axis. The x,z axis is shown at the bottom of each panel, while the y,z axis is
shown to the right of the panel . Negative controls at each stage showed a
lack of immunoreactivity following preabsorption of antibodies with the
peptide immunogen (N-P). Abbreviations: R; retina, ON; optic nerve. Scale
bars = 50 μm. Scale bar in B applies to B-D, F-H, and J-L, scale bar in E
applies to E, I and M.
Additional file 4: Figure S4. HDAC8 localization pattern in developing
murine optic nerve. (A) Low magnification confocal micrograph showing
the P30 optic nerve (ON), optic nerve head and retina (R) double-labeled
for SOX2 (glia, (green) and HDAC8 (red). Optic nerve sections at E16 (B-E),
P5 (F-I) and P30 (J-M) were triple-labeled with DAPI (blue), SOX2 (green)
and HDAC8 (red). (B, F, J) Overlays of SOX2 and DAPI to aid in orientation
of the image. Subsequent panels did not include DAPI to better show
the co-localization of the SOX2 and HDAC8 labels. (C, G, K) HDAC8; (D, H, L)
double-label of SOX2 and HDAC8. Arrows indicate nuclei that were co-
labeled with SOX2 and HDAC8. Composite images in E, I and M show z
stacks of optic nerve at high magnification; horizontal yellow lines
correspond the x axis plane and vertical yellow lines corresponds to the y
axis. The x,z axis is shown at the bottom of each panel, while the y,z axis is
shown to the right of the panel . Negative controls at each stage showed a
lack of immunoreactivity following preabsorption of antibodies with the
peptide immunogen (N-P). Abbreviations: R; retina, ON; optic nerve. Scale
bars = 50 μm. Scale bar in B applies to B-D, F-H, and J-L, scale bar in E
applies to E, I and M.
Additional file 5: Figure S5. HDAC9 localization pattern in developing
murine optic nerve. (A) Low magnification confocal micrograph showing
the P30 optic nerve (ON), optic nerve head and retina (R) double-labeled
for SOX2 (glia, (green) and HDAC9 (red). Optic nerve sections at E16 (B-E),
P5 (F-I) and P30 (J-M) were triple-labeled with DAPI (blue), SOX2 (green)
and HDAC9 (red). (B,F, J) Overlays of SOX2 and DAPI to aid in orientation
of the image. Subsequent panels did not include DAPI to better show
the co-localization of the SOX2 and HDAC9 labels. (C, G, K) HDAC9; (D, H, L)
double-label of SOX2 and HDAC9. Composite images in E, I and M show z
stacks of optic nerve at high magnification; horizontal yellow lines
correspond the x axis plane and vertical yellow lines corresponds to the y
axis. The x,z axis is shown at the bottom of each panel, while the y,z axis is
shown to the right of the panel . Negative controls at each stage showed a
lack of immunoreactivity following preabsorption of antibodies with the
peptide immunogen (N-P). Abbreviations: R; retina, ON; optic nerve. Scale
bars = 50 μm. Scale bar in B applies to B-D, F-H, and J-L, scale bar in E
applies to E, I and M.
Additional file 6: Figure S6. HDAC10 localization pattern in developing
murine optic nerve. (A) Low magnification confocal micrograph showing
the P30 optic nerve (ON), optic nerve head and retina (R) double-labeled
for SOX2 (glia, (green) and HDAC10 (red). Optic nerve sections at E16 (B-E),
P5 (F-I) and P30 (J-M) were triple-labeled with DAPI (blue), SOX2 (green) and
HDAC10 (red). (B, F, J) Overlays of SOX2 and DAPI to aid in orientation of
the image. Subsequent panels did not include DAPI to better show the
co-localization of the SOX2 and HDAC10 labels. (C, G, K) HDAC10; (D, H, L)
double-label of SOX2 and HDAC10. Composite images in E, I and M show z
stacks of optic nerve at high magnification; horizontal yellow lines
correspond the x axis plane and vertical yellow lines corresponds to the y
axis. The x,z axis is shown at the bottom of each panel, while the y,z axis is
shown to the right of the panel . Negative controls at each stage showed a
lack of immunoreactivity following preabsorption of antibodies with the
peptide immunogen (N-P). Abbreviations: R; retina, ON; optic nerve. Scale
bars = 50 μm. Scale bar in B applies to B-D, F-H, and J-L, scale bar in E
applies to E, I and M.
Additional file 7: Figure S7. HDAC11 localization pattern in developing
murine optic nerve. (A) Low magnification confocal micrograph showing
the P30 optic nerve (ON), optic nerve head and retina (R) double-labeled
for SOX2 (glia, (green) and HDAC11 (red). Optic nerve sections at E16 (B-E),
P5 (F-I) and P30 (J-M) were triple-labeled with DAPI (blue), SOX2 (green) and
HDAC11 (red). (B, F, J) Overlays of SOX2 and DAPI to aid in orientation of
the image. Subsequent panels did not include DAPI to better show the
co-localization of the SOX2 and HDAC11 labels. (C, G, K) HDAC11; (D, H, L)
double-label of SOX2 and HDAC11. Arrows indicate nuclei that wereco-labeled with SOX2 and HDAC11. Composite images in E, I and M show z
stacks of optic nerve at high magnification; horizontal yellow lines
correspond the x axis plane and vertical yellow lines corresponds to the y
axis. The x,z axis is shown at the bottom of each panel, while the y,z axis is
shown to the right of the panel . Negative controls at each stage showed a
lack of immunoreactivity following preabsorption of antibodies with the
peptide immunogen (N-P). Abbreviations: R; retina, ON; optic nerve. Scale
bars = 50 μm. Scale bar in B applies to B-D, F-H, and J-L, scale bar in E
applies to E, I and M.
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